255 results on '"Du Pasquier R"'
Search Results
2. Is disease activity prior to fingolimod initiation predictive of response? Fingolimod as a “common” first line treatment
3. First-ever treatment in multiple sclerosis
4. Diagnosis and Management of Neuromyelitis Optica
5. Two patients with acute meningoencephalitis concomitant with SARS‐CoV‐2 infection
6. Long-Term Consequences of COVID-19: A 1-Year Analysis
7. Neurologie : ce qui a changé en 2022 [Neurology: what's new in 2022]
8. Neurologie [Neurology : what's new in 2021]
9. Advances in Treatment of Progressive Multifocal Leukoencephalopathy
10. CSF lactate for accurate diagnosis of community-acquired bacterial meningitis
11. Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis
12. Posterior spinal cord infarctions due to neurosyphilis
13. Minimal supportive treatment in natalizumab-related PML in a MS patient
14. Neurologie [Recent Advances in Neurology]
15. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
16. Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
17. Complications neurologiques du virus SARS-CoV-2: une controverse de plus ?
18. Rivastigmine for HIV-associated neurocognitive disorders: A randomized crossover pilot study
19. Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
20. Assessment of HIV-infected patients with neurological complications in a multi-disciplinary platform: OS3218
21. Progressive multifocal leukoencephalopathy in a patient with transitory lymphopenia
22. Rivastigmine for the Treatment of HIV-Associated Neurocognitive Disorders: A Randomized, Double-Blind, Placebo-Controlled, Crossover Pilot Study (S37.005)
23. Micro-Structural Alterations in the Brain of Well-Treated HIV+ Patients with Mild Neurocognitive Disorders: A Multi-Contrast MRI Study at High Field (S37.001)
24. Rapid Increase of Astrocytic and Inflammatory Markers in the Cerebrospinal Fluid of HIV+ Patients on LPV/r-Monotherapy (S57.006)
25. Fatal PML associated with efalizumab therapy: Insights into integrin L 2 in JC virus control
26. PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis
27. Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis
28. Attaques cérébrovasculaires ischémiques multiples dues à une méningovasculite à Borrelia garinii
29. EFNS guidelines on diagnosis and management of neuromyelitis optica
30. Encephalitis with herpes simplex-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome?
31. Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML)
32. L - 14 Description inaugurale d’un syndrome de Cogan survenu chez une patiente Cogan positif
33. L-7 Haute prévalence de troubles cognitifs chez des patients VIH + avec viremie indetectable
34. Neuromyelitis optica following CMV primo‐infection
35. Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0
36. Detection of JC Virus-Specific Cytotoxic T Lymphocytes in Healthy Individuals
37. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy
38. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy
39. Severe but reversible encephalopathy associated with cefepime
40. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis
41. Periodic downbeat nystagmus
42. How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well‐treated HIV‐positive population?
43. Inaugural description of Cogan syndrome in an HIV-infected person
44. Longitudinal automated detection of white-matter and cortical lesions in relapsing-remitting multiple sclerosis
45. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons
46. Multiple sclerosis lesion fingerprint using quantitative MRI multicontrast analysis
47. The cellular immune response against JC virus is instrumental in the containment of progressive multifocal leukoencephalopathy
48. Multiple Sclerosis lesion fingerprint using multicontrast MRI
49. Cerebellar connectomics provide new biomarkers in early multiple sclerosis
50. Encephalitis with herpes simplex-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.